No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
ADC Therapeutics Achieves Profitability With ZYNLONTA
HC Wainwright & Co. Reiterates Buy on ADC Therapeutics, Maintains $8 Price Target
Positive Buy Rating Driven by Promising ADC Therapeutics Trial and Financial Projections
ADC Therapeutics SA (NYSE:ADCT) Not Doing Enough For Some Investors As Its Shares Slump 35%
Is ADC Therapeutics SA (NYSE:ADCT) Worth US$2.0 Based On Its Intrinsic Value?
ADC Spikes After Enrollment Update on Confirmatory Trial for Lymphoma Therapy